GaltPharma

Galt was founded with the premise of contributing to patient therapeutic needs by acquiring older proven yet viable pharmaceutical products which still address unmet needs in the current healthcare environment. The company applies superior pharmaceutical, managed care, clinical and marketing expertise to acquire, license and develop niche pharmaceutical products for distribution through a unique industry disrupting sales model. Galt currently owns FDA approved assets in the insomnia and pain markets, with products offering clinical advantages compared to currently promoted products in their respective therapeutic classes.